Skip to main content
. 2022 Feb 3;11(2):e01014-21. doi: 10.1128/mra.01014-21

TABLE 1.

Genome profiles and AMR results for the four Vibrio strains

Strain no. Organism GenBank accession no. SRA accession no. Genome size (Mbp) No. of reads Genome coverage (×) No. of contigs N50 (bp) GC content (%) No. of genes AMR phenotypea Plasmid type Predicted mobility Plasmid genotype
ISF-22-6 V. alginolyticus JAILXO010000000 SRR15526828 5.2 468,108 90 73 343,022 44.4 4,719 AMP, SXT, TE, SF, OT (E, KF) Unknown Nonmobilizable CARB-19, tet(35), aph(3″)-Ib, aph(6)-Id, floR, sul2
ISF-208-6 V. cholerae JAILXN010000000 SRR15526827 4.4 726,913 160 82 206,565 47.4 4,127 AMP, CTX, K, S, KF, CTF, PIP, OX, E (ENO) IncA/C2 Conjugative varG, catB9, sul1, aac(6′)-IId, catB3, sul1, mphA, PER3
ISF-232-3 V. parahaemolyticus JAILXM010000000 SRR15526826 5.1 190,219 30 161 80,238 45.3 4,639 AMP, CTX, K, KF, CTF (E) IncQ1 Mobilizable aac(6′)-IIa, ANT(2″)-Ia, VEB-5
ISF-238-3 V. parahaemolyticus JAILXL010000000 SRR15526825 5.4 592,288 465 85 195,494 45.3 4,990 AMP, S, SF, OT (CTF, E, KF) Unknown Nonmobilizable aph(3″)-Ib, aph(6)-Id, floR, sul2
a

AMP, ampicillin; CTF, ceftiofur; CTX, cefotaxime; E, erythromycin; ENO, enrofloxacin; K, kanamycin; KF, cephalothin; OT, oxytetracycline; OX, oxolinic acid; PIP, piperacillin; S, streptomycin; SF, sulfafurazole; SXT, sulfamethoxazole-trimethoprim; TE, tetracycline. Abbreviations shown in parentheses refer to intermediate resistance.